Pediatr. praxi. 2020;21(5):364-368 | DOI: 10.36290/ped.2020.075
Kawasaki shock syndrome
- 1 Pediatrická klinika LF MU a FN, Brno
- 2 Klinika dětských infekčních nemocí LF MU a FN, Brno
- 3 Oddělení dětské kardiologie Pediatrické kliniky LF MU a FN, Brno
Kawasaki disease (KD) was described more than 50 years ago and is still rare in our country. Etiopathogenesis KD has not been elucidated yet and similar findings of auxilliary examinations are missing. KD diagnosis still depends on the sequence of clinical signs that allow the determination of the classical variant of KD, but also the incomplete variant. Occasionally, it has been reported that some KD patients might present hemodynamic instability with severe shock symptoms. Herein we describe our experience with this serious course of KD.
Keywords: Kawasaki shock syndrome, heart failure, hypotension, immunoglobulins, corticosteroids.
Published: October 16, 2020 Show citation
References
- Burns JC, Kushner HI, Bastian JF et al. Kawasaki disease: a brief history. Pediatrics 2000; 106: e27.
Go to original source... 
Go to PubMed... - Nagata S. Causes of Kawasaki disease - from past to present. Front. Pediatr. 2019; 7: 18. Go to original source... Go to PubMed...
- Kanegaye JT, Wilder MS, Molkara D et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009, 123(5); e783-e789. Go to original source... Go to PubMed...
- Ma L, Zhang YY, Yu HG. Clinical manifestations of Kawasaki disease shock syndrome. Clin Pediatr (Phila) 2018; 57(4): 428-435. Go to original source... Go to PubMed...
- Lin YJ, Cheng MC, Lo MH, Chien SJ. Early differentiation of Kawasaki disease shock syndrome and toxic shock syndrome in a pediatric intensive care unit. Pediatr Infect Dis J 2015; 34(11): 1163-1167. Go to original source... Go to PubMed...
- Taddio A, Dei Rossi E, Monasta L et al. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol 2017; 36(1): 223-228. Go to original source... Go to PubMed...
- Li Y, Zheng Q, Zou L et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN‑γ as biomarkers for early recognition. Pediatric Rheumatology 2019; 17: 1. Go to original source... Go to PubMed...
- Lin KH, Chang SS, Yu CW et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta‑analysis. BMJ Open 2015; 5: e006703. Go to original source... Go to PubMed...
- Cakan M, Gemici H, Aktay‑Ayaz N et al. Kawasaki disease shock syndrome: a rare and severe complication of Kawasaki disease. Turk J Pediatr 2016; 58: 415-418. Go to original source... Go to PubMed...
- De Rosa G, Andreozzi L, Piastra M et al. Acute myocarditis as a revealing clue of complete Kawasaki disease. Rheumatol 2018; 70(2): 115-116. Go to original source... Go to PubMed...
- Qiu H, Li C, He Y et al. Association between left ventricular ejection fraction and Kawasaki disease shock syndrome. Cardiol Young 2019; 29(2): 178-184. Go to original source... Go to PubMed...
- Falcini F, Capannini, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatric Rheumatology 2011; 9: 17. Go to original source... Go to PubMed...
- Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol 2016; 174: 203-217. Go to original source... Go to PubMed...
- Chen KYH, Messina N, Germano S et al. Innate immune responses following Kawasaki disease and toxic shock syndrome. PLoS ONe 2018; 13(2): e019830. Go to original source...
- Yozgat Y, Uzuner S, Demir AD et al. A 13-year‑old boy who has Kawasaki disease shock syndrome presents with parotitis. Pediatr intensive care 2020; 9(1): 60-63. Go to original source... Go to PubMed...
- Gamez GLB, Moribe QI, Cisneros CM et al. Kawasaki disease shock syndrome: unique and severe subtype of Kawasaki disease. Pediatr Int 2018; 60: 781-790. Go to original source... Go to PubMed...
- Suga K, Inoue M, Ono A et al. Early combined treatment with steroid and immunoglobulin is effective for serious Kawasaki disease complicated by myocarditis and encephalopathy. J Med Invest 2016; 63: 140-143. Go to original source... Go to PubMed...
- Sato T, Somura J, Maruo Y. Steroid pulse therapy for Kawasaki disease complicated with myocarditis. Indian Pediatrics 2016; 53: 1015-1016. Go to original source... Go to PubMed...
- Marchesi A, de Jacobis IT, Riganate D et al. Kawasaki disease: guidelines of Italian society of pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow‑up, lifestyle and prevention of cardiovascular risks. Italian Journal of Pediatrics 2018; 44: 103. Go to original source... Go to PubMed...
- Abe Y, Ayuasawa M, Kawamura K et al. A combination therapy for Kawasaki disease with severe complications: a case report. Open Med 2020; 15: 8-13. Go to original source... Go to PubMed...
- Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol 2016; 67: 1738-1749. Go to original source... Go to PubMed...
- Dietz SM, vanStijn D, Burgner D et al. Dissecting Kawasaki disease: a state‑of‑the‑art review. Eur J Pediatr 2017; 176(8): 995-1009. Go to original source... Go to PubMed...
- Dionne A, Dahdah N. Myocarditis and Kawasaki disease. Int J Rheum Dis 2018; 21(1): 45-49. Go to original source... Go to PubMed...
- Moussa T, Wagner‑Wiener L. Kawasaki disease: beynod IVIG and aspirin. Pediatr Ann 2019; 48(10): e400-e405. Go to original source... Go to PubMed...
- Soni PR, Noval Rivas M, Arditi M. Comprehensive update on Kawasaki disease vasculitis and myocarditis. Curr Rheumatol Rep 2020; 22(2): 6. Go to original source... Go to PubMed...